Human papillomaviruses, p16 INK4a and Akt expression in basal cell carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Paolini, Francesca ^a   Carbone, Angelo ^a   Benevolo, Maria ^a   Silipo, Vitaliano ^b   Rollo, Francesca ^a   Covello, Renato ^a   Piemonte, Paolo ^a,b   Frascione, Pasquale ^a,b   Capizzi, Rodolfo ^c   Catrical, Caterina ^b   Venuti, Aldo ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

BCC; HPVs; p16 INK4a and Akt1 2; skin cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN KINASE B BETA; VIRUS DNA; AKT1 PROTEIN, HUMAN; AKT2 PROTEIN, HUMAN; MESSENGER RNA; P16 PROTEIN, HUMAN; PROTEIN KINASE B; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREHEAD; HUMAN; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS TYPING; WART VIRUS; BIOSYNTHESIS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; SKIN TUMOR; VIROLOGY;

CARCINOMA, BASAL CELL; DNA, VIRAL; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SKIN NEOPLASMS; UP-REGULATION;

EID: 81055124197     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-108     Document Type: Article

References (46)

1. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Bernard H-U, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, et al. Virology 2010 401 70 79 10.1016/j.virol.2010.02.002 20206957
2. Classification of papillomaviruses. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, Virology 2004 324 17 27 10.1016/j.virol.2004.03.033 15183049 (Pubitemid 38737395)
3. Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins. Bravo IG, Alonso A, Virus Genes 2007 34 249 262 10.1007/s11262-006- 0017-4 16927128 (Pubitemid 46474927)
4. Multiple evolutionary mechanisms drive papillomavirus diversification. Gottschling M, Stamatakis A, Nindl I, Stockfleth E, Alonso A, Bravo IG, Mol Biol Evol 2007 24 1242 1258 10.1093/molbev/msm039 17344207 (Pubitemid 47343645)
5. Papillomaviruses and cancer: from basic studies to clinical application. zur H, Hausen, Nat Rev Cancer 2002 2 342 350 10.1038/nrc798 12044010 (Pubitemid 37328947)
6. Molecular analyses and prognostic relevance of HPV in head and neck tumors. Badaracco G, Rizzo C, Mafera B, Pichi B, Giannarelli D, Rahimi SS, Vigili MG, Venuti A, Oncol Rep 2007 17 931 9 17342339
7. Presence of HPV in head and neck tumors: high prevalence in tonsillar localization. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M, J Exp Clin Cancer Res 2004 23 561 566 15743024
8. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Orth G, Semin Immunol 2006 18 362 374 10.1016/j.smim.2006.07.008 17011789 (Pubitemid 44511885)
9. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM, J Med Virol 2000 61 289 97 10.1002/1096-9071(200007)61:3<289::AID-JMV2>3.0.CO;2-Z 10861635 (Pubitemid 30368527)
10. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumors and normal skin. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG, J Gen Virol 1999 80 2437 2443 10501499 (Pubitemid 29408373)
11. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J, J Clin Microbiol 1995 33 690 695 7751378
12. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N, Fuchs P, Pfister H, Cancer Res 2005 65 1394 1400 10.1158/0008-5472.CAN-04-3263 15735026 (Pubitemid 40270167)
13. Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors. O'Shaughnessy RF, Akgl B, Storey A, Pfister H, Harwood CA, Byrne C, Cancer Res 2007 67 8207 8215 10.1158/0008-5472.CAN-07-0755 17804734 (Pubitemid 47395157)
14. Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. Patel As, Karagas MR, Perry AE, Nelson HH, J Invest Dermatol 2008 128 2888 2893 10.1038/jid.2008.162 18548109
15. Viral DNA detection and RAS mutations in actinic keratosis and non melanoma skin cancers. Zaravinos A, Kanellou P, Spandidos DA, Br J Dermatol 2010 162 325 331 10.1111/j.1365-2133.2009.09480.x 19849697
16. INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D, von Knebel Doeberitz M, Int J Cancer 2001 92 276 284 10.1002/ijc.1174 11291057 (Pubitemid 32225381)
17. INK4a is predictive of HR-HPV infection in cervical low-grade lesions. Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, Mariani L, Sperduti I, Canalini P, Donnorso RP, Vocaturo A, Mod Pathol 2006 19 384 91 10.1038/modpathol.3800551 16415792 (Pubitemid 43276992)
18. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Menges CW, Baglia LA, Lapoint R, McCance DJ, Cancer Res 2006 66 5555 5559 10.1158/0008-5472.CAN-06-0499 16740689 (Pubitemid 43927104)
19. AKT-dependent HspB1 (Hsp27) activity in epidermal development. O'Shaughnessy RF, Welti JC, Cooke JC, Avilion AA, Monks B, Birnbaum MJ, Byrne C, J Biol Chem 2007 282 17297 17305 10.1074/jbc.M610386200 17439945 (Pubitemid 47093238)
20. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM, Cancer Cells 1989 7 209 214
21. A general primer GP5(+)/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 highrisk and 6 low-risk human papillomavirus genotypes in cervical scrapings. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer, Walboomers JM, J Clin Microbiol 1997 35 791 795 9041439 (Pubitemid 27083888)
22. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA, Science 1988 239 487 491 10.1126/science.2448875 2448875 (Pubitemid 18084310)
23. INK4a in nonmelanoma skin cancer. Nindl I, Meyer T, Schmook T, Ulrich C, Ridder R, Audring H, Sterry W, Stockfleth E, Dermatol Surg 2004 30 409 414 10.1111/j.1524-4725.2004.30111.x 15008871 (Pubitemid 38524162)
24. Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Pérez-Tenorio G, Stål O, Southeast Sweden Breast Cancer Group, Br J Cancer 2002 86 540 545 10.1038/sj.bjc.6600126 11870534 (Pubitemid 34185089)
25. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group. Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A, Int J Cancer 2000 86 118 121 10.1002/(SICI)1097-0215(20000401)86: 1<118::AID-IJC18>3.0.CO;2-2 10728604 (Pubitemid 30133996)
26. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. O'Connor DP, Kay EW, Leader M, Atkins GJ, Murphy GM, Mabruk MJ, J Clin Pathol 2001 54 539 542 10.1136/jcp.54.7.539 11429426 (Pubitemid 32642943)
27. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, Dillner J, de Villiers EM, J Infect Dis 2007 196 876 883 10.1086/521031 17703418 (Pubitemid 47378937)
28. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, Pawlita M, J Natl Cancer Inst 2006 98 389 95 10.1093/jnci/djj092 16537831
29. Seropositivity for human papillomavirus and incidence of subsequent squamous celland basal cell carcinomas of the skin in patients with a previous nonmelanoma skin cancer. Paradisi A, Waterboer T, Sampogna F, Tabolli S, Simoni S, Pawlita M, Abeni D, Br J Dermatol 2011 165 782 91 10.1111/j.1365-2133.2011. 10403.x 21561438
30. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Rollison DE, Pawlita M, Giuliano AR, Iannacone MR, Sondak VK, Messina JL, Cruse CW, Fenske NA, Glass LF, Kienstra M, Michael KM, Waterboer T, Gheit T, Tommasino M, Int J Cancer 2008 123 2337 42 10.1002/ijc.23795 18729188
31. Cancer cell cycles. Sherr CJ, Science 1996 274 5293 1672 7 Review 10.1126/science.274.5293.1672 8939849 (Pubitemid 26414890)
32. Overexpression of cyclin D1 in mouse skin carcinogenesis. Bianchi AB, Fischer SM, Robles AI, Rinchik EM, Conti CJ, Oncogene 1993 8 1127 33 8479737 (Pubitemid 23129834)
33. Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation. Yamamoto H, Ochiya T, Takeshita F, Toriyama-Baba H, Hirai K, Sasaki H, Sasaki H, Sakamoto H, Yoshida T, Saito I, Terada M, Cancer Res 2002 62 1641 7 11912134 (Pubitemid 34408483)
34. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M, Cancer Res 1999 59 4876 81 10519399 (Pubitemid 29472891)
35. INK4a in nonmelanoma skin cancer. Nindl I, Meyer T, Schmook T, Ulrich C, Ridder R, Audring H, Sterry W, Stockfleth E, Dermatol Surg 2004 30 409 14 10.1111/j.1524-4725.2004.30111.x 15008871 (Pubitemid 38524162)
36. Enhanced expression of p16 in seborrhoeic keratosis; a lesion of accumulated senescent epidermal cells in G1 arrest. Nakamura S, Nishioka K, Br J Dermatol 2003 149 560 5 10.1046/j.1365-2133.2003.05589.x 14510989 (Pubitemid 37281588)
37. INK4a expression and infiltrative behavior. Nilsson K, Svensson S, Landberg G, Mod Pathol 2004 17 1464 74 10.1038/modpathol.3800220 15257310 (Pubitemid 39627072)
38. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Conscience I, Jovenin N, Coissard C, Lorenzato M, Durlach A, Grange F, Birembaut P, Clavel C, Bernard P, Eur J Dermatol 2006 16 518 22 17101472 (Pubitemid 44861826)
39. p16 gene expression in basal cell carcinoma. Eshkoor SA, Ismail P, Rahman SA, Oshkour SA, Arch Med Res 2008 39 668 73 10.1016/j.arcmed.2008.06.003 18760195
40. INK4a and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Svensson S, Nilsson K, Ringberg A, Landberg G, Cancer Res 2003 63 1737 42 12702553 (Pubitemid 36460829)
41. Differential ErbB1 signaling in squamous cellversus basal cell carcinoma of the skin. Rittié L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, Michael LE, Fisher GJ, Johnson TM, Elder JT, Am J Pathol 2007 170 2089 2099 10.2353/ajpath.2007.060537 17525275 (Pubitemid 47339281)
42. Significance of the expression of phosphorylated-STAT3, -Akt, and -ERK1 2 in several tumors of the epidermis. Lin N, Moroi Y, Uchi H, Fukiwake N, Dainichi T, Takeuchi S, Takahara M, Tu Y, Furue M, Urabe K, J Dermatol Sci 2007 48 71 73 10.1016/j.jdermsci.2007.06.011 17686614 (Pubitemid 47284806)
43. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations. Hafner C, Landthaler M, Vogt T, Exp Dermatol 2010 19 222 7 10.1111/j.1600-0625.2009.01056. x
44. Somatic mutations are present in all members of the AKT family in endometrial carcinoma. Dutt A, Salvesen HB, Greulich H, Sellers WR, Beroukhim R, Meyerson M, Br J Cancer 2009 101 1218 1219 10.1038/sj.bjc.6605301 19738612
45. Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Soung YH, Lee JW, Nam SW, Lee JY, Yoo NJ, Lee SH, Oncology 2006 70 285 289 10.1159/000096289 17047397 (Pubitemid 44670169)
46. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. Kim MS, Jeong EG, Yoo NJ, Lee SH, Br J Cancer 2008 98 1533 1535 10.1038/sj.bjc.6604212 18392055 (Pubitemid 351652321)